Literature DB >> 12209977

Viruses and Hodgkin disease: no evidence of novel herpesviruses in non-EBV-associated lesions.

Alice Gallagher1, Jacqueline Perry, Lesley Shield, June Freeland, Jane MacKenzie, Ruth F Jarrett.   

Abstract

The Epstein-Barr virus (EBV) is associated with a proportion of cases of Hodgkin disease (HD) and this association is believed to be causal. Epidemiological studies suggest that an infectious agent is involved in the aetiology of young adult HD, however, cases in this age group are less likely to have EBV-associated disease than cases diagnosed in early childhood or older adult years. Molecular studies have failed to find a consistent association between HD and other candidate viruses, and the aetiology of non-EBV-associated cases remains obscure. We looked for evidence of herpesvirus infection in samples of non-EBV-associated HD using a highly sensitive, degenerate PCR assay. Despite exhaustive sequence analysis of PCR products, no novel herpesviruses were identified. These results suggest that it is extremely unlikely that a novel herpesvirus is involved in the pathogenesis of non-EBV-associated HD. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12209977     DOI: 10.1002/ijc.10603

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  11 in total

1.  A protective role for early oral exposures in the etiology of young adult Hodgkin lymphoma.

Authors:  Wendy Cozen; Ann S Hamilton; Peng Zhao; Muhammad T Salam; Dennis M Deapen; Bharat N Nathwani; Lawrence M Weiss; Thomas M Mack
Journal:  Blood       Date:  2009-09-08       Impact factor: 22.113

2.  Antibody titers against EBNA1 and EBNA2 in relation to Hodgkin lymphoma and history of infectious mononucleosis.

Authors:  Nancy E Mueller; Evelyne T Lennette; Kathryn Dupnik; Brenda M Birmann
Journal:  Int J Cancer       Date:  2011-08-30       Impact factor: 7.396

3.  Atypical prediagnosis Epstein-Barr virus serology restricted to EBV-positive Hodgkin lymphoma.

Authors:  Lynn I Levin; Ellen T Chang; Richard F Ambinder; Evelyne T Lennette; Mark V Rubertone; Risa B Mann; Michael Borowitz; Edward G Weir; Susan L Abbondanzo; Nancy E Mueller
Journal:  Blood       Date:  2012-09-12       Impact factor: 22.113

4.  DNA methylation patterns in EBV-positive and EBV-negative Hodgkin lymphomas.

Authors:  Myriam Ben Dhiab; Sonia Ziadi; Sarra Mestiri; Riadh Ben Gacem; Feryel Ksiaa; Mounir Trimeche
Journal:  Cell Oncol (Dordr)       Date:  2015-09-08       Impact factor: 6.730

5.  Interleukin-2, interleukin-12, and interferon-gamma levels and risk of young adult Hodgkin lymphoma.

Authors:  Wendy Cozen; Parkash S Gill; Muhammad T Salam; Alexandra Nieters; Rizwan Masood; Myles G Cockburn; W James Gauderman; Otoniel Martínez-Maza; Bharat N Nathwani; Malcolm C Pike; David J Van Den Berg; Ann S Hamilton; Dennis M Deapen; Thomas M Mack
Journal:  Blood       Date:  2007-12-12       Impact factor: 22.113

Review 6.  Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma.

Authors:  G Kapatai; P Murray
Journal:  J Clin Pathol       Date:  2007-12       Impact factor: 3.411

7.  Interdigitating dendritic cell sarcoma of salivary gland associated lymphoid tissue not associated with HHV-8 or EBV infection.

Authors:  N Barwell; R Howatson; R Jackson; A Johnson; R F Jarrett; G Cook
Journal:  J Clin Pathol       Date:  2004-01       Impact factor: 3.411

8.  EBV in Hodgkin Lymphoma.

Authors:  Giuseppina Massini; Doerte Siemer; Stefan Hohaus
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-11-24       Impact factor: 2.576

9.  Measles virus: evidence of an association with Hodgkin's disease.

Authors:  D Benharroch; Y Shemer-Avni; Y-Y Myint; A Levy; E Mejirovsky; I Suprun; Y Shendler; I Prinsloo; S Ariad; B Rager-Zisman; M Sacks; J Gopas
Journal:  Br J Cancer       Date:  2004-08-02       Impact factor: 7.640

10.  Germ-line transmitted, chromosomally integrated HHV-6 and classical Hodgkin lymphoma.

Authors:  Adam J Bell; Alice Gallagher; Timothy Mottram; Annette Lake; Eleanor V Kane; Tracy Lightfoot; Eve Roman; Ruth F Jarrett
Journal:  PLoS One       Date:  2014-11-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.